About: Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review
Creator	Cornara, Laura Pastorino, Giulia Rodrigues, Francisca Soares, Sónia Beatriz, \| Oliveira, P Requimte, Laqv
Source	Medline; PMC
abstract	In the last years, consumers are paying much more attention to natural medicines and principles, mainly due to the general sense that natural compounds are safe. On the other hand, there is a growing demand by industry for plants used in traditional medicine that could be incorporated in foods, nutraceuticals, cosmetics, or even pharmaceuticals. Glycyrrhiza glabra Linn. belongs to the Fabaceae family and has been recognized since ancient times for its ethnopharmacological values. This plant contains different phytocompounds, such as glycyrrhizin, 18β‐glycyrrhetinic acid, glabrin A and B, and isoflavones, that have demonstrated various pharmacological activities. Pharmacological experiments have demonstrated that different extracts and pure compounds from this species exhibit a broad range of biological properties, including antibacterial, anti‐inflammatory, antiviral, antioxidant, and antidiabetic activities. A few toxicological studies have reported some concerns. This review addresses all those issues and focuses on the pharmacological activities reported for G. glabra. Therefore, an updated, critical, and extensive overview on the current knowledge of G. glabra composition and biological activities is provided here in order to explore its therapeutic potential and future challenges to be utilized for the formulation of new products that will contribute to human well‐being.
has issue date	2018-08-17(xsd:dateTime)
bibo:doi	10.1002/ptr.6178
bibo:pmid	30117204
has license	no-cc
sha1sum (hex)	bc4eb0e12627efca9c1e676a345b6ad802fd688a
schema:url	https://doi.org/10.1002/ptr.6178
resource representing a document's title	Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review
has PubMed Central identifier	PMC7167772
has PubMed identifier	30117204
schema:publication	Phytother Res
resource representing a document's body	covid:bc4eb0e12627efca9c1e676a345b6ad802fd688a#body_text
is schema:about of	named entity 'EXPERIMENTS' named entity 'NATURAL' named entity 'TRADITIONAL MEDICINE' named entity 'ADDRESSES' named entity 'STUDIES' named entity 'BROAD' named entity 'USED' named entity 'REPORTED' named entity 'Vero cells' named entity 'active ingredients' named entity 'liquorice' named entity 'flavonoids' named entity 'GABA A receptors' named entity 'depression' named entity 'sweet taste' named entity 'ulcer' named entity 'endometrial cancer' named entity 'sedative' named entity 'long-term' named entity 'forced swim test' named entity 'mitochondrial dysfunction' named entity 'H. pylori' named entity 'sterols' named entity 'piebaldism' named entity 'glabridin' named entity 'serum' named entity 'HSV' named entity 'Glycyrrhizin' named entity 'glabridin' named entity 'caspase-8' named entity 'metabolism' named entity 'tyrosinase' named entity 'Glabridin' named entity 'vesicular stomatitis virus' named entity 'liquorice' named entity 'glycyrrhizin' named entity 'osteomalacia' named entity 'anaesthetics' named entity 'solar lentigines' named entity 'phosphorus' named entity 'HIV-1' named entity 'upper respiratory tract' named entity 'low-density lipoprotein' named entity 'glabridin' named entity 'antioxidant activities' named entity 'liquorice' named entity 'oxidative stress' named entity 'capillary vessel' named entity 'antioxidant activity' named entity 'liquorice' named entity 'multidrug-resistant' named entity 'S. aureus' named entity 'active compound' named entity 'glabridin' named entity 'HIV-1' named entity 'cytokine' named entity 'infection' named entity 'sweetening agents' named entity 'biological activity' named entity 'severe acute respiratory syndrome virus' named entity 'liquorice' named entity 'oestrogenic' named entity 'MRSA' named entity 'intraperitoneal injection' named entity 'antigen' named entity 'cough' named entity 'Hepatoprotective' named entity 'stomach' named entity 'Bcl-2' named entity 'liquiritin' named entity 'dietary supplement' named entity 'HIV' named entity 'antimicrobial activity' named entity 'AST' named entity 'copper'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software